| abstract |
The present invention relates to a pharmaceutical combination comprising a acidic drug in combination with a leukotriene D4 antagonist, and more particularly, to a daily combination of a stanco-based drug such as doxophylline or theophylline together with a leukotriene D4 antagonist such as montelukast. A pharmaceutical formulation for treating allergic diseases in a single use. Therefore, the pharmaceutical formulation according to the present invention improves the convenience of taking the patient as a daily one-time use of each individual drug, as well as allergic diseases such as bronchial asthma, damp, eczema, dermatitis, psoriasis, There is a significantly elevated effect compared to the treatment of allergic rhinitis. |